Evofem CEO Demands Overhaul of Women’s Health at Fierce JPM Week 2026

Reuters01-26
Evofem CEO Demands Overhaul of Women’s Health at Fierce <a href="https://laohu8.com/S/JPM">JPM</a> Week 2026

Evofem Biosciences Inc. CEO Saundra Pelletier delivered a powerful keynote address at Fierce JPM Week 2026, calling for a fundamental reset in women’s health. Pelletier highlighted the historical neglect of women’s health issues, stating, “If men suffered from endometriosis, it would be solved by now,” and criticized the exclusion of women from clinical trials due to perceptions about hormonal complexity. She emphasized Evofem’s commitment to prioritizing transparency, education, and respect in their approach to women’s health. The full keynote, titled “Rebuilding Women’s Health from the Ground Up,” is available for on-demand viewing via Fierce Pharma. Register for Fierce JPM Week 2026 and scroll to "Friday, January 23" to access the session.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evofem Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260123678836) on January 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment